Detail akcie GeneDx Hldg Rg online

Business Summary: GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, GeneDx Holdings Corp revenues increased 46% to $306.6M. Net loss decreased 94% to $3.4M. Revenues reflect Legacy Sema4 segment increase of 5% to $3M. Lower net loss reflects Other expense, net increase from $12.3M (expense) to $274K (income), FV Adjustments of Financial Investments decrease of 80% to $2.3M (expense).